학술논문
The efficacy of Zafirlukast as a SARS-CoV-2 helicase inhibitor in adult patients with moderate COVID-19 Pneumonia (pilot randomized clinical trial)
Document Type
Article
Author
Source
In Journal of Infection and Public Health December 2022 15(12):1546-1550
Subject
Language
ISSN
1876-0341